Genemed Biotechnologies, Inc. offers immunohistochemistry (IHC) and Chromogenic In Situ Hybridization services for pharmaceutical, biotechnology, and academic research institutes.

We have more than 40 years of experience in IHC/ISH reagent development and manufacturing for manual and automation systems including antibodies, probes, conjugation and detection reagents, staining data interpretation, as well as knowledge in quality system regulations (QSRs) and in vitro diagnostic medical device regulations.

We have established quality management systems to meet standards in the IVD industry, which include international standards ISO 13485:2003 Medical Devices, and FDA 21CFR Part 820 Quality System Regulation.

If you are interested in learning more about our IHC & CISH services, please contact us at 1(877)GENEMED (436-3633), or you can email us.